The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: Not only psychopathology matters by Vos, J. (Joël) et al.
The counselees’ self-reported request for psychological help
in genetic counseling for hereditary breast/ovarian cancer:
not only psychopathology matters
Joël Vos1*, Christi J. van Asperen1, Jan C. Oosterwijk2, Fred H. Menko3, Margriet J. Collee4, Encarna Gomez Garcia5
and Aad Tibben6
1Department of Clinical Genetics, Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands
2Department of Clinical Genetics, University Medical Center, Groningen University, Groningen, The Netherlands
3Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands
4Department of Clinical Genetics, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands
5Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands
6Department of Clinical Psychology, Vrije Universiteit Amsterdam, Asmterdam, The Netherlands
*Correspondence to:
Department of Clinical Genetics,
Center for Human and Clinical
Genetics, Leiden University
Medical Center, Leiden, The
Netherlands. E-mail: A.Tibben@
lumc.nl
Received: 16 May 2011
Revised: 3 February 2012
Accepted: 19 March 2012
Abstract
Background: Several studies have shown that counselees do not experience psychopathological levels
of distress after DNA test result disclosure. However, it has not systematically been studied whether
the absence of psychopathology also means that counselees do not want to receive help. Their self-
reported request for help may be related not only with psychopathology/distress but also with other
psychological needs (e.g., surgery decisions), genetics-specific needs (e.g., feeling vulnerable/
stigmatized), and existential concerns (e.g., meaning in life).
Methods: Questionnaires were filled in by Dutch cancer patients, before and after disclosure of
BRCA1/2 test results for hereditary breast/ovarian cancer: pathogenic mutation results (n= 30),
uninformative results (n= 202), or unclassified variants (n= 16). Newly developed questions measured
request for help, psychopathology was estimated with factor analyses on distress/psychopathology
instruments, and several validated questionnaires measured other needs/concerns.
Results: One-third of all counselees who reported a request for psychological help had actually received
help. The level of psychopathology correlated between 0.34 and 0.44 with this self-reported need-for-help.
Other needs, genetics-specific distress, and existential concerns correlated strongly/moderately with the
counselees’ self-reported need-for-help. Examples of other needs were intention to undergo surgery, inaccu-
racy of their interpretation, the impact of cancer, and family communication difficulties. Genetics-specific
distress was for instance feeling vulnerable to develop cancer, stigma, and lack of mastery. Existential con-
cerns were, among others, lack of purpose in life, low self-acceptance, and an unfulfilled wish for certainty.
Conclusions: The request for help is related to multiple factors. Referral to psychosocial professionals
may be improved by not only discussing psychopathology during genetic-counseling sessions but also by
other needs and existential concerns. Questions about other needs and existential issues may be added to
psychological screening instruments.
Copyright © 2012 John Wiley & Sons, Ltd.
Introduction
In genetic counseling for hereditary cancer, the genetic
counselor usually explores the potential psychological
consequences of DNA testing with the counselee and
provides emotional support. Some counselees may benefit
from referral to a psychologist or social worker, as
suggested by national and international guidelines [1,2].
Psychologists may offer psychotherapeutic counseling,
and a social worker may help with psychosocial issues
(in the Netherlands, a social worker is a professional with
a bachelor title, who mainly focuses on psychosocial issues
instead of psychotherapy). However, which counselees
should be referred to a psychologist or social worker?
Until recently, psychologists and social workers with
specific expertise in genetic counseling were frequently
and intensively involved in the care of patients who
received genetic counseling, for instance as standard
procedure in genetic counseling in the Netherlands. It was
assumed that genetic counseling may be a psychologically
difficult process, which may evoke psychopathological
levels of distress in some counselees (e.g., clinically
diagnosed depression or anxiety), although the operationali-
zation and the level of distress seemed to be a matter of
debate (e.g., [3–8]). Recently, the support of a specialized
psychologist or social worker is becoming a non-standard
element of genetic counseling, especially regarding
oncogenetics. Counselees may request and receive psycho-
logical help for a broad range of reasons, but this help is
not automatically offered. This transformation in the
psychosocial care for counselees may partially be attributed
to the relatively small number of counselees showing long-
term psychopathological levels of distress, andmost of them
seem to cope relatively adequately with the DNA test result
[7–16].
Thus, counselees do not receive help from a psychologist
or social worker as standard care, probably because of these
studies suggesting the absence of distress. Individual
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counselees may be referred for a broad range of reasons
especially when obvious psychopathological levels of
distress seem present (clinical experience). Referral may
therefore not always meet the counselees’ actual needs
(cf., [17]). Thus, the policy and practice of referral to a
psychologist or social worker seem to be based on the
presence/absence of psychopathology in counselees. This
strategy can be criticized for four reasons, which will lead
us to the research questions of our empirical study. We will
focus on literature about BRCA1/2 counseling, because
the majority of all DNA tests are performed in genes for
hereditary breast and/or ovarian cancer.
1. Unclear need - Authors such as Coyne et al. [7] seem to
suggest that the presence/absence of psychopathology
may imply that counselees do not actually need psycho-
logical care: ‘it may be that the mental health issues
associated with genetic testing for risk of breast and
ovarian cancer are being overemphasized’. However,
the counselees’ self-reported request for psychological
help may not correspond with psychopathological
levels of distress as found by instruments measuring
general distress. For instance, some patients may
have questions/worry about their intention to undergo
prophylactic mastectomy for which they need to
receive help as this worry may be very disturbing in
their lives, but may not necessarily have to reach levels
of psychopathology [18]. Other patients may report
psychopathology (e.g., depression or anxiety), but
may not need psychological help because they have
enough psychological and social coping resources.
Thus, counselees may have needs or concerns besides
psychopathology and which may directly result in
distress. It may be advised to focus on the self-reported
need of counselees instead of deriving their request for
help from the presence/absence of psychopathology
(cf., [17,19–21]). The relationship between psychopa-
thology and the self-reported request for psychological
help has not systematically been studied yet in genetic
counseling.
2. Genetics-specific distress - Several researchers used
general instruments for distress and psychopathology,
and additionally, instruments dedicated for genetics-
specific concerns/distress have been developed [16].
Several recent studies used genetics-specific instru-
ments, and these data suggest that many counselees
may not experience psychopathological levels of
distress but they may report feelings of vulnerability,
stigma, uncertainty, and lack of perceived control,
for which they may like to receive psychological help
[22–25]. We call this ‘distress’ and not ‘other needs’,
because this focuses on emotional aspects; that is,
distress has been defined as ‘a multifactorial unpleasant
emotional experience of a psychological (cognitive,
behavioral, emotional), social and/or spiritual nature
that may interfere with the ability to cope effectively
with cancer’ [26]. The level of distress may be so
high that a clinician may formally diagnose a
psychopathological disorder. The relationship between
genetics-specific distress and the self-reported request
for help may need further exploration.
3. Other needs - It remains unclear why some counselees
request for help and why others do not. Among various
reasons may not only be psychopathology. For instance,
counselees have also reported other psychological
needs (apart from their request for information, which
may be fulfilled by the genetic counselor); these needs
may cause their request for receive psychological
help, such as dealing with the emotional impact of can-
cer, uncertainty, vulnerability and feeling stigmatized,
problems in making medical decisions, social isolation,
familial context, previous experiences with cancer in
themselves and/or in their relatives, having difficulties
understanding, and misinterpreting the DNA test result
[7,18,27–37]. Between 25% and 39% of all counselees
have reported that their request for emotional support
was not satisfied and they wished additional psycho-
logical help [31,38]. Thus, counselees report many
reasons to receive help other than distress; this may have
been overlooked because of the focus on distress. The
reasons/predictors of the self-reported request for psy-
chological help have not been systematically studied yet.
4. Existential concerns - Existential and spiritual con-
cerns, such as the counselees’ perceived certainty and
purpose in life, and fundamental request for certainty
about cancer and its heredity, have not systematically
been studied, despite their reported importance for
many counselees (e.g., [39–42]). Genetic counseling
may inherently be regarded as an existential process,
in which medical information is embedded in their
sense of self and their lives in general [25,37].
These four considerations led us to the formulation
of the following study questions:
1. How many counselees report that they need
psychological help, and how many of them do
actually receive psychological help?
2. In what way is this self-reported request for psycho-
logical help related to (i) psychopathology and (ii)
non-psychopathology factors, that is, other needs,
genetics-specific distress, and existential concerns?
Method
Procedure and samples
Eligible participants were women with breast and/or
ovarian cancer who had requested a BRCA1/2 test in the
period 2006–2009 at the departments of Clinical Genetics
of the Leiden University Medical Center, the Maastricht
University Medical Center, the University Medical Central
Groningen, ErasmusMedical Center Rotterdam, or the VU
Medical Center Amsterdam. Eligible counselees received
two questionnaires: immediately after the first genetic-
counseling session/intake (T1) and 3 months after the
second genetic-counseling session in which the DNA test
result was disclosed (T2, i.e., 4–6 months after T1).
Usually, genetic counselors disclosed the following
information: DNA test result category, heredity likelihood,
cancer risks for female relatives and for the counselee, and
risk management options (surgery, surveillance) for rela-
tives and counselees, including the possibility for relatives
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to undergo DNA testing when applicable. More informa-
tion on the procedure and sample, such as informed
consent and approval by all relevant medical ethical
committees, are described elsewhere [25,43].
Instruments
We selected the instruments on the basis of suggestions in
the literature as described in the Introduction (Table 1).
The request for psychological help was measured on a
7-point Likert scale ranging from ‘no need’ (1) to ‘strong
need’ (7): ‘Would you like to talk with a psychologist or
social worker?’ (cf., [17,19–21]). Other formulations were
also used, and we also asked about the counselees’ inten-
tions to actually ask for help; these formulations did not
lead to significant differences, and therefore, we only used
this question. These questions about the request for
psychological help were part of 15 questions by which
we asked the counselees’ request to receive help or referral
to several professions (e.g., surgeon, radiology); at follow-up,
dichotomic questions measured whether they had actually
received help from these professions.
The level of psychopathology was estimated with sev-
eral instruments measuring psychopathology, to be in line
with previous studies in which these psychopathology
instruments were used. We assumed that genetic counsel-
ing may increase a general feeling of psychopathology
and that it may not make sense to specify the types of psy-
chopathology. For this reason, and because of parsimony
and limited textual space, we used principal component
analyses (PCAs) with Varimax rotation, and we decided
on the number of factors on the basis of the eigenvalues,
scree plot, Variance-Explained-For (VAF/R²), interpret-
ability, and Cronbach’s alpha. Unpresented PCA results
can be requested from the authors. For each participant,
we calculated scores on the created factors by using
regression analyses. PCA suggested ‘negativity’ and
‘worry’ as two factors underlying the scores on the Hospital
Anxiety and Depression Scale, Positive Affect Negative
Affect Scale, Lerman’s Cancer Worry Scale, and Impact
of Events Scale [44–48]. Negativity measured general as
well as cancer-specific negative emotions. Worry measured
general and cancer-specific worry. Analyses without data
reduction yielded similar results (unpresented).
We decided to measure other needs similar to the afore-
mentioned studies. The intentions to undergo surgery or
surveillance during the coming 6 months were measured
on 7-point Likert scales. The counselees’ interpretation of
their own risks and of the likelihood that cancer is heritable
in the family was measured [40,43,49]. The familial con-
text was measured with the openness to discuss hereditary
cancer in the nuclear family and the family of origin [34],
the number of affected and deceased relatives (collected
from medical files), and the number of children. The
perceived impact of cancer on their lives was measured
with the Illness Perception Questionnaire (IPQ; [50]);
similar items of the IPQ assessed whether other life events
during the last 6 months had influenced their lives. We
used several questions regarding the medical history
and sociodemographics as frequently used [51]. Genetics-
specific distresswas measured with Esplen’s BRCA-related
self-concept scale; PCA confirmed that this scale consisted
of feeling stigmatized, feeling vulnerable to developing can-
cer, and experiencing reduced mastery over cancer [24,35].
The 8-item Life Changes Questionnaire was used to
measure the impact of DNA testing on several life domains;
PCA indicated that two factors were measured by this scale:
medical changes and psychological–existential changes
[49]. Existential concerns were measured with reliable,
valid scales: Ryff’s eudaimonic well-being scale [52],
optimism [53], and the Unfulfilled Need for Certainty Scale
[49].
Statistics
Question 1
We calculated the number and percentage of counselees
with a request for psychological help at T1 and T2 (i.e.,
scores of 5, 6, or 7 on the 7-point Likert scale) and the
number/percentage of counselees who reported actually
receiving help.
Question 2
We used Pearson’s correlations (cf., beta in simple
regression analyses) to correlate the counselees’ self-
reported request for psychological help with the predictors
in Table 1. Subsequently, we performed partial correlation
analyses to correct these relationships for the level of
psychopathology (i.e., negativity and worry); by doing
this, we tried to see the unique effects of these non-
psychopathology predictors on the self-reported request
for help.
For presentation purposes, we present only significant
correlations in the text; non-significant relationships and
exact figures can be found in the tables. Using T1 scores
as covariate in analyses of T2 scores did not lead to differ-
ent scores and are therefore not presented. Multiple regres-
sion analysis was not possible because of multicollinearity
and conceptual overlap of variables; structural equation
modeling was impossible because of the large number of
estimated parameters relative to the sample size. Only
moderate or large effects (R> 0.20, p< 0.01) are presented.
We did not perform a stricter correction of statistical errors
such as Bonferroni, because we wanted to balance two
arguments. On the one hand, this is an explorative study with
rather specific expectations about the direction of most corre-
lations, which suggests using high p-values (e.g., p< 0.10) to
avoid type II statistical error, that is, rejecting a hypothesis
when it is actually true. On the other hand, we performed
many tests, which increased the possibility of type I error, that
is, accepting our hypothesis when it is actually false;
therefore, we used p< 0.01 as significance criterion. We
did not include information about the actually communicated
DNA test result [25,49], because neither did this correlate
with the request for help nor was it a significant covariate
or confounder. We call a correlation small when R< 0.23,
moderate when R=0.24–0.26, and large when R> 0.37.
Results
Description of sample
We approached 654 women who had undergone
BRCA1/2 testing. Of them, 467 (71%) filled in the T1
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questionnaire, and subsequently, 248 (53%) filled in the
T2 questionnaire after disclosure of pathogenic mutation
results (n= 30), uninformative results (n = 202), or
unclassified variants (n=16) (no significant differences
were found in the outcome variables in this study and
are therefore not discussed separately in the text). See
Table 2; more information is published elsewhere
[25,37,49].
Description of the self-reported request for help
After the intake (T1), 27% of all counselees reported
a request for psychological help (score≥ 5 on a
7-point scale; mean, m= 3.6; standard deviation, sd= 1.5).
After the disclosure of the DNA test (T2), 20% needed to
receive psychological help (m= 3.2, sd= 1.3). At T1, 20%
of all counselees received help (which is 34% of all
Table 1. Overview of predictors and contextual factors, including instruments used in our analyses
Instrument Scales
Range of
total scores
Explained
variance if
PCA; alpha
Psychopathology Hospital Anxiety and Depression Scale
Impact of Events Scale; Positive Affect
Negative Affect Scale; Lerman’s Cancer
Worry [44–48] (T1, T2)
2 PCA factors: 1. Negativity with strong values on: anxiety,
depression, positive and negative affects; 2. Worry
with strong values on: cancer worry, avoidance,
intrusions, anxiety
Individual scores
calculated with
regression (overall:
m=0, sd=1)
0.40; 0.90
0.37; 0.87
Other needs Medical decisions intended in the next
6 months (PCA) (T1, T2)
Composite scales: 1. Intended breast surveillance (3 items),
i.e., breast self-examination, surveillance of breasts by
physician, and mammography; 2. intended mastectomy;
3. intended surveillance of ovaries (2 items): surveillance
by physician; blood sample; 4. intended bilateral
salpingo-oophorectomy
Individual regression
scores (overall:
m=0, sd=1)
0.27; 0.87
0.27; 0.87
0.19; 0.90
Interpretations [37,40,49,76] 1. Interpretation of own cancer risks (i.e., thoughts
and feelings regardless of what the genetic counselor has
communicated). 2. Interpretation of the likelihood that
cancer is heritable in the family. 3. Extent of accuracy of
interpretation of own cancer risks as indicated by
difference between the actually communicated risks
(derived from medical files) and the interpretation of
one’s own risks (larger score =more inaccurate)
1–7 (not likely/low
risk–very likely/
high risk)
Single items
Family relationships: openness to discuss
hereditary cancer in the nuclear family [34];
information (T1, T2)
1. Openness to discuss hereditary cancer in the
nuclear family. 2. Openness in family from origin.
3. Pedigree information in medical files: numbers, percentages,
and years of with cancer-affected and deceased 1st, 2nd,
and/or 3rd degree relatives
1: 7–35 (closed–
open). 2: 7–35
(closed–open).
3: %, n, year
Composite scores,
no PCA
Illness perception questionnaire, IPQ-R
[50] (T1, T2)
Single items: influence of cancer on life, duration of cancer,
control over cancer, treatment control over cancer, physical
complaints, worry about cancer, understanding cancer,
influence from cancer on mood
1–10 (few–many) Single items
Influence from other life events (items from
the IPQ were used) (T1, T2)
Single items: influence of events on life, worry about
events, influence from event on mood
1–10 (few–many) Single items
Medical history (T1, T2) 1. Breast or ovarian cancer. 2. Metastases. 3. Kind of
cancer treatment: mastectomy, bilateral salpingo-
oophorectomy, chemotherapy, radiotherapy, other
therapy. 4. Years since disclosure of cancer
diagnoses, metastases, treatment and of genetic counseling
0–1 (no–yes) Single items
Sociodemographics (T1) 1. Living together with a partner. 2. Having children.
3. Number of children, sons, daughters. 4.Number of children
at home. 5. Being religious. 6. Having a job. 7. Number of
hours of job. 8. Educational level ranging from none
(0)–university (7). 9. Age
0–1 (no–yes) or N Single items
Genetics-specific
distress
BRCA-related self-concept [24,35] (T1, T2) PCA confirmed 3 scales: 1. Stigma (7 items).
2. Vulnerability (5 items). 3. Lack of mastery (4 items)
7–49 (none–a lot);
5–35 (none–a lot);
4–28 (none–a lot)
0.30; 0.75
0.22; 0.73
0.19; 0.59
Life Changes Questionnaire [37,40] (T1, T2) Composite scales confirmed by PCA: changes in
life because DNA test result attributed to
DNA testing: (1) psychological–existential changes
(3 items), (2) physical–medical changes (5 items)
3–15 (none–a lot);
7–35 (none–a lot)
0.20; 0.67
0.40; 0.83
Existential
concerns
Ryff ’s eudaimonic well-being scales
[51] (T1, T2)
Composite scales: 1. Environmental mastery.
2. Purpose in life. 3. Self-acceptance. 4. Autonomy.
5. Personal growth. 6. Enjoying relationships.
7. Vitality. 8. Inner strength
6–36 (little–much) Composite scales
Revised life orientation scale [52] (T1, T2) Optimism; composite scale of 10 items 10–50 (not/very
optimistic)
Composite scale
Unfulfilled need for certainty scale
[49] (T1, T2)
Unfulfilled need for certainty about: DNA test
result, heredity, cancer, self (unfulfilled = need for
certainty is larger than perceived certainty; fulfilled =
perceived certainty is larger than need for certainty)
DNA: 6–42
(fulfilled–unfulfilled).
Other : 5–35
(fulfilled–unfulfilled)
0.88; 0.85
0.86; 0.89
0.85; 0.87
0.84; 0.85
Data in bold show significance in the analyses of T1 and/or T2 (Table 4).
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counselees with a request for help), and at T2 4% received
help (29% of those with a need). See Table 3.
Predictors of the self-reported request for help
This paragraph describes the significant predictors of the
request for help; Table 4 shows the figures for the signif-
icant outcomes and also the non-significant predictors.
The psychopathological factors ‘negativity’ and
‘worry’ correlated moderately/strongly (R= 0.34, 0.44)
with the request for psychological help at T1 and T2
(see figures in Table 4).
One other need correlated moderately/strongly
(R=0.24–0.44) with this need at T1 and/or T2, also after
correction for the level of psychopathology: intention to
undergo mastectomy or bilateral salpingo-oophorectomy.
Several other needs correlated moderately (R=0.20, 0.36)
with this request for help: influence from cancer, worry
about cancer and influence from cancer on mood, and
number of children at home; these needs became non-
significant at T1 when corrected for the level of psychopa-
thology. The counselees’ interpretation of their cancer
risks, heredity likelihood, and the accuracy of the interpreta-
tion of their own risks did not significantly correlate with the
request for help at T1; the interpretations correlated moder-
ately with the need at T2 (R= 0.20, 0.28), and the accuracy
of the interpretation of their own risks correlated strongly
(R=0.37) with the request for help at T2 when corrected
for the level of psychopathology. Family relationships,
medical history, and other sociodemographic variables did
not significantly correlate with the request for help. Open
communication style with the family correlated moderately
with the request for help (R=0.20, 0.29).
The genetics-specific distress-variables vulnerability,
stigma, and mastery correlated moderately/strongly
with the request for help at T1 and T2 (R= 0.24, 0.43).
Medical–physical and psychological–existential changes
correlated moderately with the need at T2 (R= 0.25, 0.26).
Most existential concerns correlated moderately with the
request for help at T1 and T2 (R= 0.20, 0.37): mastery,
purpose self-acceptance, personal, growth, vitality, and
need for certainty about the DNA test result, heredity,
cancer, and self. At T1, the effects of all existential
concerns became small or not significant when corrected
for the level of psychopathology; at T2, the effects remained
moderate after correction.
Discussion
The results suggest that the counselees’ self-reported
request for help in genetic counseling is not only deter-
mined by the level of their psychopathology, because both
were only correlated between 0.34 and 0.44. Thus, the
presence of psychopathology may not necessarily imply
a request for psychological help, and a request for help
may not only be due to psychopathology. This request
for help seems to be a multi-factorial phenomenon.
1. Other needs: A large part of the counselees’ request for
help was not correlated with psychopathology. ‘Other
needs’ as indicated by previous studies mentioned in
the Introduction section also correlated with the counse-
lees’ request for help. Examples of strong correlations
were the intention to undergo surgery, the inaccuracy
of the counselees’ interpretation of the DNA test result,
the impact of cancer, and communication difficulties
with the family. Life events other than cancer and
DNA testing did not influence the counselees’ request
for help. Thus, counselees may need to receive
psychological help regarding these cancer-related and
genetic-related topics during genetic counseling.
2. Genetics-specific distress: Compared with psycho-
pathology, distress measured with genetics-specific
instruments was an equally strong predictor of the
counselees’ self-reported request for help, which
suggests that these genetics-specific instruments were
Table 3. Overview of the number (%) of counselees with a
request for psychological help and the number who actually
receives psychological help
Request for
psychological helpa
Actual receipt of
psychological help
N (%/sample)
N (%/sample; %/request
for help)
After the intake session 101 (27%) 34 (20%; 34%)
After the DNA test
result session
34 (16%) 11 (4%; 29%)
N may differ per cell because of missing values.
aMeasured as ‘I need to receive psychological help’ on a 7-point scale (not–much);
much is defined as scores 5, 6, or 7.
Table 2. Description of study population
Variable n % Mean SD
Participation Returned questionnaire after intake 458 68
Returned questionnaire after DNA result 248 54
Cancer history Time since diagnosis (years) 5 5
Breast cancer 234 94
Ovarian cancer 14 6
Metastatic cancer 64 26
Mastectomy (BM) 139 56
Bilateral salpingo-oophorectomy (BSO) 53 11
Sociodemographics Age 56 23
Attended high school or higher 105 42
Being married 207 84
Having children 216 87
Having daughter(s) 171 69
Having son(s) 151 61
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as useful in identifying counselees who need help;
however, asking counselees about distress may yield
different answers than asking them about their request
for psychosocial help [7,24,35].
3. Existential concerns: Existential concerns correlated
moderately with the counselees’ request for help. This
may suggest that counselees who experience existential/
spiritual problems may want to receive help regarding
these questions, for example, purpose in life and self-
acceptance. Counselees may also want to receive help
when they feel that the current situation gives them
less certainty than they want to have, that is, when they
feel an unfulfilled request for certainty regarding the
DNA test result, heredity, cancer, and themselves.
These findings are in line with several studies showing
that meaning, existential issues, and spiritual well-
being are important for cancer patients to adjust to
their cancer [54–59]. Cancer patients who do not
experience meaning in life seem to be less adjusted
to cancer, experience lower well-being, and report
more distress and more depression [60–65]. Patients
who are not able to reengage in finding meaning in life
may also experience less positive mood [66].
4. Corrections: When we corrected the correlations for
the level of psychopathology at T1, several other needs
and existential concerns became not significant. How-
ever, at T2, these other needs and existential concerns
remained significant without reduction in effect sizes.
This may be explained by the fact that the level of
psychopathology can be expected to be largest in the
period between the intake session and the disclosure
of the DNA test result and immediately after the disclo-
sure; in the long term, psychopathology may decrease
(cf., [16]). This may suggest that in the period of waiting
for the DNA test result, psychopathology may actually
be a good predictor of the counselees’ request for help,
but it may not be several months after disclosure of the
DNA result, when the focus is less on psychopathology
and more other needs/concerns. Later in time, psycho-
pathology disappears but other needs and existential
concerns remain, possibly because counselees only start
understanding the consequences of the DNA test result
on the long term.
Implications
Because of logistic reasons, we could not perform a baseline
measurement (T0) of the request for help and could not use
complex statistics such as structural equation modeling.
These could be included in future studies. Other formula-
tions may be used to ask counselees about their request for
help, and the relationships between need, intention, and
actual receipt of psychological help may be explored. The
role of subjective bias and the counselees’ skills to report
their psychological needs should be examined.
A remarkable finding was that only one-third of all
counselees who reported a request for receiving help from
a psychologist or social worker had actually received such
help. This indicates that counselees should not only be
Table 4. Significant Pearson’s correlations between the self-reported need to receive psychological help, and psychopathology, other needs,
genetics-specific distress, and existential concerns
Variable
T1 T2
R Partial R R Partial R
Psychopathology Negativity 0.34 n/a 0.34 n/a
Worry 0.44 n/a 0.38 n/a
Other needs Medical intentions Intention mastectomy 0.24 0.24 0.24 0.44
Intention bilateral salpingo-oophorectomy 0.31 0.39 0.24 0.39
Interpretation Inaccuracy of interpretation of own risks ns ns 0.27 0.37
Interpretation of own cancer risk ns ns 0.28 0.25
Interpretation of heredity likelihood ns ns 0.21 0.20
Family Openness with nuclear family 0.29 0.24 0.21 0.20
Openness with family of origin 0.20 0.20 0.23 0.21
Impact of cancer Influence of cancer on life 0.36 ns 0.35 0.26
Worry 0.36 ns 0.32 0.21
Influence on mood 0.40 ns 0.29 0.28
Sociodemographics Number of children living at home 0.28 ns 0.23 ns
Genetics-specific distress BRCA self-concept Vulnerability 0.43 0.32 0.39 0.37
Stigma 0.41 0.24 0.31 0.25
Lack of mastery 0.33 0.30 0.24 0.26
Life changes since DNA test result Medical changes n/a n/a 27 0.25
Psychological–existential changes n/a n/a 0.27 0.26
Existential concerns Ryff ’s well-being scale Mastery 0.29 ns 0.26 0.21
Purpose 0.22 ns 0.30 30
Self-acceptance 0.25 ns 0.28 0.28
Personal growth 0.20 0.22 0.25 0.25
Vitality 0.29 ns 0.24 0.28
Unfulfilled need for certainty Unfulfilled need for certainty about DNA result 0.20 ns 0.24 0.25
Unfulfilled need for certainty about heredity 0.21 ns 0.27 0.31
Unfulfilled need for certainty about cancer 37 0.23 0.34 0.34
Unfulfilled need for certainty about self 0.37 0.20 0.30 0.30
R, Pearson’s correlation, all p< 0.01 and R> 0.20 (not significant variables are shown in Table 2); T1, measurement after the first intake session; T2, measurement after the disclosure
of the DNA test result; ns, not significant; n/a, not applicable; partial R, partial correlations, that is, corrected for the level of anxiety and negativity.
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referred on the basis of (the counselors’ interpretation of)
psychopathology. Genetic counselors could offer referral
to a psychologist or social worker not only when psycho-
pathology is present but also when other needs, genetics-
specific distress, or existential concerns arise.
As is already frequently happening, these themes may be
discussed during a reciprocal dialogue between the genetic
counselor and counselee [67]. In this conversation, the mean-
ing, interpretation, and consequences of the DNA test result
for the counselees may be explored [25,36,37,43,49,68].
Counselees may not ask for psychological help for
reasons other than psychopathology because they may
be anxious and/or think in stereotypes [69]. Therefore, a
genetic counselor may explicitly explain to counselees for
what kind of reasons they could be referred to a psychol-
ogist or social worker, for example, distress, difficult
decision-making, telling the family, difficulties in living
with uncertainty, or creating their identity as (non)-mutation
carrier. In the context of such an explanation, counselees
may be asked the simple question of whether they would
like to receive support for any of these reasons.
Additionally, screening instruments may be used to
identify counselees who may need to receive psychologi-
cal help. However, many instruments seem to focus
mainly on psychopathology or only ask in non-specific
terms about other needs and existential concerns. New
items may be developed to measure this. Our results sug-
gest that it may not be useful to make a ‘personal profile’
of counselees who need to receive psychological help, for
example, on the basis of the actually communicated DNA
test result, medical history, or sociodemographic vari-
ables; these variables were uncorrelated with the self-
reported request for help (except for having many children
still living at home; cf., [51]). One may simply ask the
question: ‘Would you like to speak with a social worker
or psychologist?’ (as many counselors do) [17,19–21].
In the Dutch context of this research, when counselees
asked for psychological help, they could receive help from
a psychologist or social worker with specific expertise in
genetic counseling. Such specialized psychological help
may not always be possible in all countries; in these situa-
tions, the counselee may ask for help from a psychologist
or social worker without any knowledge about genetic
counseling. It is unclear whether this general psychological
help is as effective as the specialized psychological help.
Clinical experience suggests that some psychological
issues may be easier to understand and addressed by
specialized psychological help, but more research about
this is needed.
There may be many psychotherapeutic interventions
to help counselees with their concerns during genetic
counseling. Decision-making interventions—for example,
‘decision aids’—may help making decisions between
screening and preventive surgery (e.g., [70]). Help may be
offered in communicating DNA test results to the family,
for example, by leaflets or by direct communication
between genetic counselor and the counselees’ relatives
[36,68]. The counselees’ interpretations of the DNA test
result may be discussed, and consequences for their
emotional life may be explored [25,37,49]. Existential
concerns may be targeted with existential and spiritual inter-
ventions [71–73]. The genetic risks—and the wish to know
more about these, and the worries evoked by these—may
be seen and relativized from the general context of the coun-
selees’ lives: life always includes risks and uncertainties,
and other activities, such as skydiving, may include larger
risks without receiving extensive counseling. The main
thread of all psychological interventions may be to help
counselees living with ‘dual realities’ [25,37,74] That is,
on the one hand, they may be stimulated to acknowledge
the genetic reality, and their feelings of uncertainty and
vulnerability regarding the DNA test result. On the other
hand, they may be helped in finding psychological and
social resources to regain (to some extent) a feeling of
certainty and invulnerability, to be able to live their daily
lives in a meaningful way [25,37,74,75].
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